Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
11
NMPA:11
Drug Approvals
Hydrotalcite Chewable Tablets
- Product Name
- 铝碳酸镁咀嚼片
- Approval Number
- 国药准字H20253384
- Approval Date
- Feb 20, 2025
NMPA
Levocetirizine Dihydrochloride Oral Solution
- Product Name
- 盐酸左西替利嗪口服溶液
- Approval Number
- 国药准字H20244952
- Approval Date
- Sep 19, 2024
NMPA
Paracetamol Oral Solution
- Product Name
- 对乙酰氨基酚口服溶液
- Approval Number
- 国药准字H20094205
- Approval Date
- Sep 14, 2024
NMPA
Dexibuprofen Oral Suspension
- Product Name
- 右旋布洛芬口服混悬液
- Approval Number
- 国药准字H20090073
- Approval Date
- Nov 3, 2023
NMPA
Pantoprazole Sodium Enteric-coated Capsules
- Product Name
- 泮托拉唑钠肠溶胶囊
- Approval Number
- 国药准字H20090075
- Approval Date
- Nov 3, 2023
NMPA
Compound Sulfamethoxazde Tablets
- Product Name
- 复方磺胺甲噁唑片
- Approval Number
- 国药准字H42021191
- Approval Date
- Sep 16, 2015
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found